155 related articles for article (PubMed ID: 9218585)
1. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
[TBL] [Abstract][Full Text] [Related]
2. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
[TBL] [Abstract][Full Text] [Related]
3. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition.
Zanelli E; Krco CJ; David CS
J Immunol; 1997 Apr; 158(7):3545-51. PubMed ID: 9120317
[TBL] [Abstract][Full Text] [Related]
4. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
Monji T; McCormack AL; Yates JR; Pious D
J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
[TBL] [Abstract][Full Text] [Related]
5. HLA-DQ polymorphisms are highly selective for peptide binding interactions.
Kwok WW; Nepom GT; Raymond FC
J Immunol; 1995 Sep; 155(5):2468-76. PubMed ID: 7650377
[TBL] [Abstract][Full Text] [Related]
6. Determination of the peptide binding motif and high-affinity ligands for HLA-DQ4 using synthetic peptide libraries.
Volz T; Schwarz G; Fleckenstein B; Schepp CP; Haug M; Roth J; Wiesmüller KH; Dannecker GE
Hum Immunol; 2004 Jun; 65(6):594-601. PubMed ID: 15219379
[TBL] [Abstract][Full Text] [Related]
7. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
[TBL] [Abstract][Full Text] [Related]
8. Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection.
Godkin AJ; Davenport MP; Willis A; Jewell DP; Hill AV
J Immunol; 1998 Jul; 161(2):850-8. PubMed ID: 9670963
[TBL] [Abstract][Full Text] [Related]
9. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires.
Bergseng E; Dørum S; Arntzen MØ; Nielsen M; Nygård S; Buus S; de Souza GA; Sollid LM
Immunogenetics; 2015 Feb; 67(2):73-84. PubMed ID: 25502872
[TBL] [Abstract][Full Text] [Related]
10. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
[TBL] [Abstract][Full Text] [Related]
11. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
Hill CM; Hayball JD; Allison AA; Rothbard JB
J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
[TBL] [Abstract][Full Text] [Related]
12. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.
Nepom BS; Nepom GT; Coleman M; Kwok WW
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7202-6. PubMed ID: 8692969
[TBL] [Abstract][Full Text] [Related]
13. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions.
Buckner J; Kwok WW; Nepom B; Nepom GT
J Immunol; 1996 Dec; 157(11):4940-5. PubMed ID: 8943399
[TBL] [Abstract][Full Text] [Related]
14. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.
Suri A; Walters JJ; Gross ML; Unanue ER
J Clin Invest; 2005 Aug; 115(8):2268-76. PubMed ID: 16075062
[TBL] [Abstract][Full Text] [Related]
15. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR.
Paliakasis K; Routsias J; Petratos K; Ouzounis C; Kokkinidis M; Papadopoulos GK
J Struct Biol; 1996; 117(2):145-63. PubMed ID: 8931340
[TBL] [Abstract][Full Text] [Related]
16. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein.
Nakanishi K; Komatsu Y; Kogawa N; Matsushita H
Biochem Biophys Res Commun; 2005 Apr; 329(1):356-61. PubMed ID: 15721314
[TBL] [Abstract][Full Text] [Related]
17. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31.
Wu S; Gorski J; Eckels DD; Newton-Nash DK
J Immunol; 1996 May; 156(10):3815-20. PubMed ID: 8621918
[TBL] [Abstract][Full Text] [Related]
18. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase.
Kwok WW; Domeier ML; Raymond FC; Byers P; Nepom GT
J Immunol; 1996 Mar; 156(6):2171-7. PubMed ID: 8690906
[TBL] [Abstract][Full Text] [Related]
19. Design of new high-affinity peptide ligands for human leukocyte antigen-DQ2 using a positional scanning peptide library.
Jüse U; van de Wal Y; Koning F; Sollid LM; Fleckenstein B
Hum Immunol; 2010 May; 71(5):475-81. PubMed ID: 20105447
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the structural basis and energetic landscape of susceptibility difference between HLA isotypes to allergic rhinitis.
Mao XL; Zhu F; Pan ZH; Wu GM; Zhu HY
Comput Biol Chem; 2016 Oct; 64():210-216. PubMed ID: 27433817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
